Wilson Sonsini Goodrich & Rosati advised ChargePoint on the transaction. ChargePoint, a leading electric vehicle (EV) charging network, announced a partnership with Goldman Sachs Renewable Power...
ChargePoint’s Partnership with Goldman Sachs Renewable Power
ViFive’s $5.8 Million Funding Round
Wilson Sonsini Goodrich & Rosati advised ViFive on the financing. ViFive, an innovator in Vision AI technology, announced a pre-A funding of $5.8 million. The funding...
IGM Biosciences’ $230 Million Public Offering
Wilson Sonsini Goodrich & Rosati advised IGM on the transaction. IGM Biosciences, Inc. announced the pricing of its underwritten public offering of 8,695,653 shares of its...
Remote’s $300 Million Series C Financing Round
Wilson Sonsini advised Remote on the deal, while Latham & Watkins represented SoftBank Vision Fund 2. Remote, a leader in building, managing, and supporting global, distributed...
EQRx’s Collaboration with Insilico Medicine
Ropes & Gray advised EQRx in the deal while Wilson Sonsini Goodrich & Rosati represented InSilico. EQRx annlounced a strategic collaboration with Insilico Medicine to jointly...
LayerZero Labs’ $135 Million Series A Funding Round
Lowenstein represented LayerZero Labs Ltd. in the transaction while Orrick advised PayPal Ventures. LayerZero Labs Ltd., a provider of omnichain crypto networks, executed its $135 million...
HP’s $3.3 Billion Acquisition of Poly
Davis Polk & Wardwell, Ropes & Gray and Skadden, Arps, Slate, Meagher & Flom advised HP on the deal. Wilson Sonsini Goodrich & Rosati represented Poly....
Affini-T Therapeutics’ $175 Million Financing
Latham & Watkins and Wilson Sonsini represented Affini-T Therapeutics, Inc. in the transaction. Affini-T Therapeutics, Inc., a biotechnology company unlocking the power of T cells against oncogenic...
Block Tackle’s $5 Million Seed Round
Wilson Sonsini advised Block Tackle on the deal. Block Tackle, a new game studio founded by veterans from EA and Kabam, who will develop immersive games...
Apexigen’s Business Combination Agreement with Brookline Capital Acquisition Corp.
Wilson Sonsini advised Apexigen on the deal. Apexigen, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing a new generation of antibody therapeutics for oncology,...
House Rx’s $30 Million Financing
Wilson Sonsini Goodrich & Rosati advised House Rx on the deal. House Rx, a health technology platform focused on improving affordability and patient access to specialty...
NuVasive v. Alphatec
Wilson Sonsini advised NuVasive on the deal. After a two-week jury trial NuVasive obtained a victory against spine surgery competitor Alphatec. In the early 2000s, NuVasive pioneered the eXtreme...